- Home
- ELVN vs INOD Comparison
ELVN vs INOD Comparison
Compare ELVN & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- INOD
- Stock Information
- Founded
- ELVN 2016
- INOD 1988
- Country
- ELVN United States
- INOD United States
- Employees
- ELVN N/A
- INOD N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- INOD EDP Services
- Sector
- ELVN Health Care
- INOD Technology
- Exchange
- ELVN Nasdaq
- INOD Nasdaq
- Market Cap
- ELVN 1.2B
- INOD 1.6B
- IPO Year
- ELVN 2020
- INOD 1993
- Fundamental
- Price
- ELVN $22.63
- INOD $49.72
- Analyst Decision
- ELVN Strong Buy
- INOD Strong Buy
- Analyst Count
- ELVN 5
- INOD 4
- Target Price
- ELVN $41.20
- INOD $57.50
- AVG Volume (30 Days)
- ELVN 730.4K
- INOD 2.6M
- Earning Date
- ELVN 08-12-2025
- INOD 07-31-2025
- Dividend Yield
- ELVN N/A
- INOD N/A
- EPS Growth
- ELVN N/A
- INOD 1293.88
- EPS
- ELVN N/A
- INOD 1.08
- Revenue
- ELVN N/A
- INOD $202,301,000.00
- Revenue This Year
- ELVN N/A
- INOD $44.28
- Revenue Next Year
- ELVN N/A
- INOD $22.64
- P/E Ratio
- ELVN N/A
- INOD $46.19
- Revenue Growth
- ELVN N/A
- INOD 114.21
- 52 Week Low
- ELVN $13.30
- INOD $13.02
- 52 Week High
- ELVN $30.03
- INOD $71.00
- Technical
- Relative Strength Index (RSI)
- ELVN 60.45
- INOD 54.82
- Support Level
- ELVN $19.38
- INOD $49.41
- Resistance Level
- ELVN $21.34
- INOD $53.86
- Average True Range (ATR)
- ELVN 1.27
- INOD 3.84
- MACD
- ELVN 0.11
- INOD -0.00
- Stochastic Oscillator
- ELVN 88.47
- INOD 48.89
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About INOD Innodata Inc.
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.